National survey of patient perspectives on medication costs among co-pay assistance recipients with cancer.

Authors

Anh Lam

Anh B. Lam

University of Oklahoma Health Sciences Center, Oklahoma City, OK

Anh B. Lam , Ryan David Nipp , Jill S. Hasler , Bonnie Y. Hu , Gregory J. Zahner , Sarina Robbins , Stephanie B. Wheeler , Erin K. Tagai , Suzanne M. Miller , Jeffrey M. Peppercorn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Palliative and Supportive Care

Sub Track

Integrating Patient Experience Assessment and Patient Reported Outcomes Into Practice

Citation

JCO Oncol Pract 20, 2024 (suppl 10; abstr 246)

DOI

10.1200/OP.2024.20.10_suppl.246

Abstract #

246

Poster Bd #

D16

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Genitourinary Cancers Symposium

Financial toxicity from PARP inhibitors in castrate-resistant prostate cancer.

Financial toxicity from PARP inhibitors in castrate-resistant prostate cancer.

First Author: David Joseph Benjamin

Poster

2023 ASCO Genitourinary Cancers Symposium

Patient perceptions regarding the process of obtaining oral prostate cancer medications.

Patient perceptions regarding the process of obtaining oral prostate cancer medications.

First Author: Eric B Schwartz

Poster

2020 ASCO Virtual Scientific Program

Financial toxicity and patient-reported outcomes over time: A longitudinal study of women with recurrent ovarian cancer.

Financial toxicity and patient-reported outcomes over time: A longitudinal study of women with recurrent ovarian cancer.

First Author: Larissa Meyer

Poster

2015 Genitourinary Cancers Symposium

Evaluation of the economic impact of the CCP assay in localized prostate cancer.

Evaluation of the economic impact of the CCP assay in localized prostate cancer.

First Author: E. David Crawford